HU0201262D0 - - Google Patents
Info
- Publication number
- HU0201262D0 HU0201262D0 HU0201262A HUP0201262A HU0201262D0 HU 0201262 D0 HU0201262 D0 HU 0201262D0 HU 0201262 A HU0201262 A HU 0201262A HU P0201262 A HUP0201262 A HU P0201262A HU 0201262 D0 HU0201262 D0 HU 0201262D0
- Authority
- HU
- Hungary
- Prior art keywords
- halogen
- preparing
- hydrogen
- compound
- formula
- Prior art date
Links
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 150000002431 hydrogen Chemical class 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/55—Acids; Esters
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Vascular Medicine (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12567199P | 1999-03-22 | 1999-03-22 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| HU0201262D0 true HU0201262D0 (OSRAM) | 2002-05-29 |
| HUP0201262A2 HUP0201262A2 (en) | 2002-08-28 |
| HUP0201262A3 HUP0201262A3 (en) | 2003-12-29 |
Family
ID=22420863
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0201262A HUP0201262A3 (en) | 1999-03-22 | 2000-03-21 | Process for preparing [s-(r*,s*)]-betha-[[[1-[1-oxo-3-(4-piperidinyl)propyl]-3-piperidinyl]carbonyl]amino]-3-pyridinepropanoic acid and derivatives |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US6515130B1 (OSRAM) |
| EP (1) | EP1165543B1 (OSRAM) |
| JP (1) | JP2002540108A (OSRAM) |
| KR (1) | KR20020019895A (OSRAM) |
| CN (1) | CN1351600A (OSRAM) |
| AT (1) | ATE242235T1 (OSRAM) |
| AU (1) | AU775413B2 (OSRAM) |
| BR (1) | BR0010652A (OSRAM) |
| CA (1) | CA2368024A1 (OSRAM) |
| CZ (1) | CZ20013431A3 (OSRAM) |
| DE (1) | DE60003169T2 (OSRAM) |
| DK (1) | DK1165543T3 (OSRAM) |
| ES (1) | ES2199805T3 (OSRAM) |
| HK (1) | HK1046272A1 (OSRAM) |
| HR (1) | HRP20010767A2 (OSRAM) |
| HU (1) | HUP0201262A3 (OSRAM) |
| MX (1) | MXPA01009615A (OSRAM) |
| PT (1) | PT1165543E (OSRAM) |
| SK (1) | SK13562001A3 (OSRAM) |
| UA (1) | UA67832C2 (OSRAM) |
| WO (1) | WO2000056730A1 (OSRAM) |
| YU (1) | YU74601A (OSRAM) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1364159A (zh) | 1999-03-22 | 2002-08-14 | 奥索-麦克尼尔药品公司 | 丙酸3－氨基－3－芳基酯的合成 |
| EP1674456B1 (en) * | 2001-09-21 | 2008-07-16 | Sanofi-Aventis | Use of 2-fluoro- 3-ketoesters for preparing 3-fluoro-6,7,8,9-tetrahydro-4-H-pyrimdo[1,2-a]pyrimidin-4-ones |
| MY174617A (en) | 2011-08-17 | 2020-05-01 | Life Molecular Imaging Sa | Compounds for binding to the platelet specific glycoprotein iib/iiia and their use for imaging of thrombi |
| WO2014124943A1 (en) | 2013-02-12 | 2014-08-21 | Bayer Pharma Aktiengesellschaft | Metal chelate compounds for binding to the platelet specific glycoprotein iib/iiia |
| KR102236806B1 (ko) | 2013-02-20 | 2021-04-06 | 로이터 케미쉐 아파라테바우 이.카. | 거울상 이성질체 농후화된 3-아미노피페리딘의 제조 방법 |
| WO2014173855A1 (en) | 2013-04-22 | 2014-10-30 | Reuter Chemische Apparatebau Kg | Process for preparing enantiomerically enriched 3-hydroxymethylpiperidine |
| KR102548998B1 (ko) | 2020-03-31 | 2023-06-29 | 재단법인 아산사회복지재단 | 혈전영상을 위한 방사성의약품 및 조성물 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE58243B1 (en) | 1983-12-07 | 1993-08-11 | Lonza Ag | A process for the preparation of optically-active 3-amino carboxylic acids |
| US5254573A (en) | 1991-10-15 | 1993-10-19 | Monsanto Company | Substituted heterocyclic derivatives useful as platelet aggregation inhibitors |
| TW401414B (en) * | 1993-09-22 | 2000-08-11 | Fujisawa Pharmaceutical Co | <beta>-alanine derivative and a process for the preparation thereof |
| US5770575A (en) * | 1994-03-16 | 1998-06-23 | Ortho Pharmaceutical Corporation | Nipecotic acid derivatives as antithrombotic compounds |
| CA2248809A1 (en) * | 1996-03-13 | 1997-09-18 | Fujisawa Pharmaceutical Co., Ltd. | N-[(r)-1-{3-(4-piperidyl)propionyl}-3-piperidylcarbonyl]-2(s)-acetylamino-beta-alanine as fibrinogen receptor antagonist |
| BR9710434A (pt) * | 1996-05-01 | 1999-08-17 | Ortho Pharma Corp | Derivados de carboxiamida de pirrolidina piperidina e hexahidroazepina para o tratamento de desordens trombÄticas |
| ES2167758T3 (es) | 1996-07-12 | 2002-05-16 | Searle & Co | Sintesis asimetrica de beta-aminoacidos quirales. |
| US6066651A (en) * | 1997-10-29 | 2000-05-23 | Ortho-Mcneil Pharmaceutical, Inc. | Orally-active nipecotamide glycolamide esters for the treatment of thrombosis disorders |
-
2000
- 2000-03-21 EP EP00916573A patent/EP1165543B1/en not_active Expired - Lifetime
- 2000-03-21 US US09/532,375 patent/US6515130B1/en not_active Expired - Lifetime
- 2000-03-21 KR KR1020017012100A patent/KR20020019895A/ko not_active Withdrawn
- 2000-03-21 JP JP2000606591A patent/JP2002540108A/ja active Pending
- 2000-03-21 MX MXPA01009615A patent/MXPA01009615A/es unknown
- 2000-03-21 SK SK1356-2001A patent/SK13562001A3/sk unknown
- 2000-03-21 DE DE60003169T patent/DE60003169T2/de not_active Expired - Fee Related
- 2000-03-21 CN CN00807617A patent/CN1351600A/zh active Pending
- 2000-03-21 PT PT00916573T patent/PT1165543E/pt unknown
- 2000-03-21 YU YU74601A patent/YU74601A/sh unknown
- 2000-03-21 BR BR0010652-6A patent/BR0010652A/pt not_active IP Right Cessation
- 2000-03-21 CZ CZ20013431A patent/CZ20013431A3/cs unknown
- 2000-03-21 DK DK00916573T patent/DK1165543T3/da active
- 2000-03-21 UA UA2001096538A patent/UA67832C2/uk unknown
- 2000-03-21 AT AT00916573T patent/ATE242235T1/de not_active IP Right Cessation
- 2000-03-21 HU HU0201262A patent/HUP0201262A3/hu unknown
- 2000-03-21 ES ES00916573T patent/ES2199805T3/es not_active Expired - Lifetime
- 2000-03-21 HK HK02107463.1A patent/HK1046272A1/zh unknown
- 2000-03-21 AU AU37661/00A patent/AU775413B2/en not_active Ceased
- 2000-03-21 HR HR20010767A patent/HRP20010767A2/hr not_active Application Discontinuation
- 2000-03-21 CA CA002368024A patent/CA2368024A1/en not_active Abandoned
- 2000-03-21 WO PCT/US2000/007462 patent/WO2000056730A1/en not_active Ceased
-
2002
- 2002-02-22 US US10/081,289 patent/US20020137937A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| DE60003169D1 (de) | 2003-07-10 |
| SK13562001A3 (sk) | 2002-08-06 |
| ATE242235T1 (de) | 2003-06-15 |
| HUP0201262A2 (en) | 2002-08-28 |
| UA67832C2 (uk) | 2004-07-15 |
| US6515130B1 (en) | 2003-02-04 |
| MXPA01009615A (es) | 2003-07-21 |
| US20020137937A1 (en) | 2002-09-26 |
| HRP20010767A2 (en) | 2002-12-31 |
| YU74601A (sh) | 2004-05-12 |
| JP2002540108A (ja) | 2002-11-26 |
| CA2368024A1 (en) | 2000-09-28 |
| WO2000056730A1 (en) | 2000-09-28 |
| EP1165543A1 (en) | 2002-01-02 |
| HK1046272A1 (zh) | 2003-01-03 |
| AU3766100A (en) | 2000-10-09 |
| PT1165543E (pt) | 2003-10-31 |
| DK1165543T3 (da) | 2003-09-29 |
| DE60003169T2 (de) | 2005-10-27 |
| BR0010652A (pt) | 2002-07-16 |
| ES2199805T3 (es) | 2004-03-01 |
| AU775413B2 (en) | 2004-07-29 |
| HUP0201262A3 (en) | 2003-12-29 |
| EP1165543B1 (en) | 2003-06-04 |
| CN1351600A (zh) | 2002-05-29 |
| KR20020019895A (ko) | 2002-03-13 |
| CZ20013431A3 (cs) | 2003-04-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW334435B (en) | Bicyclic amines | |
| CY1106743T1 (el) | Μεθοδος παρασκευης θειαμεθοξαμης | |
| NO20002676D0 (no) | Androgene steroidforbindelser og en fremgangsmÕte for fremstilling og anvendelse av samme | |
| MX9800412A (es) | Preparacion de 3-hidroxipirazoles n-substituidos. | |
| HU0201262D0 (OSRAM) | ||
| BG105766A (en) | New process for preparing pesticidal intermediates | |
| IN187760B (OSRAM) | ||
| BG106002A (en) | Process for preparing pesticidal intermediates | |
| IL146811A0 (en) | Novel method for preparing benzoperhydroisoindole compounds | |
| MY130488A (en) | Process for preparing 3,3',6,6'-tetraalkyl-2,2'-biphenols and 3,3',6,6'-tetraalkyl-5,5'-dihalo-2,2'-biphenols | |
| MXPA03010943A (es) | Proceso para preparar un ligando de ppar de tiazol y polimorfos del mismo. | |
| WO2004009585A3 (fr) | Derives d'acyloxypyrrolidine et leur utilisation en tant que ligands des recepteurs v1b et v1a de avp | |
| GB9920959D0 (en) | Novel process | |
| ZA200005110B (en) | Process for preparing intermediates. | |
| TNSN01117A1 (en) | Process for preparing 2- (4-pyridyl) amino -6- dialkyloxyphenyl-pyrido [2,3 -d] pyrimidin-7-ones | |
| MY133207A (en) | Substituted benzolactam compaunds | |
| NZ284474A (en) | Process for preparing 5,6-dihydroxy-2-amino-1,2,3,4-tetrahydronaphthalene derivatives | |
| GB9906328D0 (en) | 2-Substituted RNA preparation | |
| MY120806A (en) | Improved process for preparing pharmaceutically valuable norbenzomorphane derivatives. | |
| IL152696A0 (en) | Process for the preparation of pesticidal compounds | |
| TW358809B (en) | Phenylamidinothiophene compound and anti-inflammatory agent containing the same | |
| GB9919071D0 (en) | Deposition compounds | |
| WO1999011621A3 (en) | Thiourea for increasing hdl-cholesterol levels, which are useful as anti-atherosclerotic agents | |
| ATE258545T1 (de) | Antioxidantien, verfahren zu ihrer herstellung und ihre verwendungen | |
| MX9605794A (es) | Intermediario para preparar un compuesto farmaceuticamente activo. |